(19)
(11) EP 1 545 605 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.05.2010 Bulletin 2010/21

(45) Mention of the grant of the patent:
25.11.2009 Bulletin 2009/48

(21) Application number: 03750381.0

(22) Date of filing: 02.10.2003
(51) International Patent Classification (IPC): 
A61K 39/39(2006.01)
 A61L 15/44(2006.01)
(86) International application number:
PCT/DK2003/000654
(87) International publication number:
WO 2004/030696 (15.04.2004 Gazette 2004/16)

(54)

COMPOSITION FOR VACCINATION

ZUSAMMENSETZUNG ZUR IMPFUNG

COMPOSITION VACCINALE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 02.10.2002 DK 200201473
02.10.2002 US 415102 P

(43) Date of publication of application:
29.06.2005 Bulletin 2005/26

(73) Proprietor: Nordic Vaccine A/S
2100 Copenhagen Ø (DK)

(72) Inventors:
  • KIKRBY, Nikolai, Soren
    DK-2200 Copenhagen N (DK)
  • SAMUELSEN, Peter, Borman
    DK-2960 Rungsted Kyst (DK)

(74) Representative: Aagaard, Louise Yung 
Høiberg A/S St. Kongensgade 59 A
1264 Copenhagen K
1264 Copenhagen K (DK)


(56) References cited: : 
WO-A-00/07621
WO-A-92/21331
WO-A-98/56420
WO-A-02/074325
WO-A1-99/43350
 WO-A-92/06710
WO-A-98/36772
WO-A-99/11247
WO-A-02/080981
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).